About PharmaVerse

KMC Healthcare is a team of highly skilled consultants to the health care sector, specialising in the provision and reimbursement of pharmaceuticals in Australia, New Zealand, Asia and Europe. They have been advising the pharmaceutical sector since 2000, and represent clients ranging from the largest multi-national manufacturers and suppliers to wholesalers and community pharmacy, as well as their representative organisations. Their expert team delivers Health Technology Assessment, PBAC & MSAC submissions, PHARMAC submissions, economic modelling, and client-focused commercialisation strategies, enabling patient access and healthcare innovations.

Sajni brings 15+ years of expertise in evidence synthesis, systematic reviews, and methodology design. Sajni is skilled at illuminating areas of unmet need by using evidence and scientific data to highlight gaps and opportunities that are critical for healthcare decision-making. She translates complex data into decision-ready outputs that inform funders, providers, policy makers, and governments. Her work supports guidelines, education, and policy development, giving clients the credible foundations needed for seamless access strategies.

CaroIine has 20+ years of experience bringing excellence in medical affairs and team leadership to pharmaceutical companies, including Eli Lilly, Novartis and Sanofi, and as Director of Markey Medical Consulting. She is skilled in specialty care and rare diseases through all stages of product life cycle from clinical trials, market access, launch preparedness, and medical education. Caroline excels in leveraging KOL and patient insights to inform strategy and create novel solutions in delivering medicines.

Caroline has 30+ years in healthcare, including senior leadership at Pfizer, Roche, Bayer, TEVA, and CSIRO. She excels in commercialisation, market research, go-to-market strategy, and access programs, with experience in oncology, ophthalmology, respiratory, and infectious disease. Known for her sharp commercial acumen and human connection, she guides teams to translate science into strategies that resonate.

Tim is a senior pharmaceutical executive with extensive experience in general management, drug development, and commercial strategy across Australia, the US and Europe. He has guided local sponsorship, R&D tax credits, business development, due diligence, commercialisation, go-to-market planning, access programs, reimbursement strategies and field force planning. With expertise in transplant, immunology, oncology, and rare diseases, Tim brings strategic insight to help clients navigate complex challenges and drive growth.

Feisia brings 15+ years in pharma, spanning Pfizer, AstraZeneca, and consulting (Lucid MedComms). She specialises in medical communications, omnichannel strategy, and AI-driven solutions that make clinical and regulatory data easier to use, share, and act on — helping teams deliver clear, compliant, and impactful content.

Jason brings 15+ years of experience in healthcare as a pharmacist, working directly with patients to understand their needs and how communication can support better health outcomes. He translates this expertise into the development of clear, compliant resources and company communications that connect patient needs with clinical practice. Jason specialises in preparing SOPs, reviewing promotional materials, and creating resources for healthcare professionals and patients. His approach ensures that pharmaceutical communications are relevant, effective, and allow companies to prioritise strategic objectives.

With a background in medical lab science and research, Josephine specialises in translating complex data into accessible medical education and scientific resources. Her expertise spans diagnostics, renal, and cardiology. She is passionate about simplifying the complex for clinicians and patients — creating content that educates, engages, and drives adherence.